Neurogene Inc.
NGNE
$17.10
$0.2951.76%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -53.25M | -47.61M | -40.98M | -36.32M | -50.96M |
| Total Depreciation and Amortization | 3.28M | 3.30M | 3.30M | 3.30M | 3.38M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -10.80M | -11.52M | -13.64M | -14.38M | 2.03M |
| Change in Net Operating Assets | -9.31M | -10.25M | -8.21M | -4.02M | 923.00K |
| Cash from Operations | -70.08M | -66.08M | -59.52M | -51.42M | -44.63M |
| Capital Expenditure | -820.00K | -735.00K | -357.00K | -321.00K | -415.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 20.96M | 20.96M | 20.96M | 20.96M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -16.95M | 11.85M | 35.00M | 5.00M | -- |
| Cash from Investing | 3.19M | 32.07M | 55.60M | 25.64M | -415.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -47.00K | -45.00K | -35.00K | -29.00K | -22.00K |
| Issuance of Common Stock | 1.19M | 1.08M | 685.00K | 168.00K | 215.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -16.00K |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 87.16M | 85.30M | 85.20M | 92.34M | -1.96M |
| Cash from Financing | 88.30M | 86.34M | 85.85M | 92.48M | -1.78M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 21.41M | 52.32M | 81.94M | 66.70M | -46.83M |
